Testing a generic eye drop for glaucoma and high eye pressure

This trial is comparing two versions of bimatoprost, an eye drop medication used to treat glaucoma (a condition where pressure builds up in your eye and can damage vision) and ocular hypertension (abnormally high eye pressure). One version is the brand-name LUMIGAN®, and the other is a generic version made by a different company. The study wants to confirm that both versions work equally well at lowering eye pressure.

Generic medications are often less expensive than brand-name versions and can make treatment more affordable for patients. Before a generic eye drop can be approved and sold, it must be proven to work just as well as the original brand-name medication.